1466: Long-Term Comparative Outcomes of Ureteroneocystostomy Techniques in Renal Transplantation

2006 ◽  
Vol 175 (4S) ◽  
pp. 473-473
Author(s):  
Jeffrey Veale ◽  
Jay Yew ◽  
David Gjertson ◽  
Gabriel Danovitch ◽  
Alan Wilkinson ◽  
...  
2021 ◽  
Vol 2 (2) ◽  
pp. 92-108
Author(s):  
Maurizio Salvadori ◽  
Aris Tsalouchos

Sexual life and fertility are compromised in end stage kidney disease both in men and in women. Successful renal transplantation may rapidly recover fertility in the vast majority of patients. Pregnancy modifies anatomical and functional aspects in the kidney and represents a risk of sensitization that may cause acute rejection. Independently from the risks for the graft, pregnancy in kidney transplant may cause preeclampsia, gestational diabetes, preterm delivery, and low birth weight. The nephrologist has a fundamental role in correct counseling, in a correct evaluation of the mother conditions, and in establishing a correct time lapse between transplantation and conception. Additionally, careful attention must be given to the antirejection therapy, avoiding drugs that could be dangerous to the newborn. Due to the possibility of medical complications during pregnancy, a correct follow-up should be exerted. Even if pregnancy in transplant is considered a high risk one, several data and studies document that in the majority of patients, the long-term follow-up and outcomes for the graft may be similar to that of non-pregnant women.


2021 ◽  
Vol 28 (1) ◽  
pp. 661-670
Author(s):  
Lawrence Kasherman ◽  
Jeffrey Doi ◽  
Katherine Karakasis ◽  
Jeffrey Schiff ◽  
Abhijat Kitchlu ◽  
...  

Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma treated with paclitaxel and bevacizumab in the context of prior renal transplantation where the patient responded well to treatment with controlled toxicities, discussing the potential for increased rates of adverse events and drug interactions in this select population.


1996 ◽  
Vol 83 (8) ◽  
pp. 1082-1085 ◽  
Author(s):  
M. L. Nicholson ◽  
T. A. McCulloch ◽  
S. J. Harper ◽  
T. J. Wheatley ◽  
C. M. Edwards ◽  
...  

1984 ◽  
Vol 8 (3) ◽  
pp. 355-363 ◽  
Author(s):  
Jaromir Svêrák ◽  
Jaroslav Peregrin ◽  
Dagmar Hejcmanová ◽  
Josef Erben

1983 ◽  
Vol 130 (2) ◽  
pp. 411-411
Author(s):  
R. Abele ◽  
A.C. Novick ◽  
W.E. Braun ◽  
B. Steinmuller ◽  
C. Buszta ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0199629 ◽  
Author(s):  
Shigeyoshi Yamanaga ◽  
Angel Rosario ◽  
Danny Fernandez ◽  
Takaaki Kobayashi ◽  
Mehdi Tavakol ◽  
...  

2013 ◽  
Vol 106 (1) ◽  
pp. 117-134 ◽  
Author(s):  
Matthew J. Bottomley ◽  
Paul N. Harden

2013 ◽  
Vol 27 (6) ◽  
pp. 838-843 ◽  
Author(s):  
Ioannis D. Kostakis ◽  
Demetrios N. Moris ◽  
Alexandros Barlas ◽  
Ioannis Bokos ◽  
Maria Darema ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document